Since 2002, BioCrossroads has worked to catalyze innovation and collaboration within Indiana’s life sciences sector. The sector has grown at a remarkable pace and has generated billions of dollars in revenue for the state with $79 billion in economic impact in 2021. BioCrossroads plays a critical role by convening academic, philanthropic, and cross-sector employer partners, enhancing research development, and working to attract life sciences businesses, innovation, and talent to Indiana.  

This unique collaborative approach has proven to be successful in times of need. At the onset of the COVID-19 pandemic, BioCrossroads played a key role convening Indiana’s life science and healthcare partners troubleshoot COVID testing, vaccine development and deployment, and other needs for Indiana residents.  

The Richard M. Fairbanks Foundation has awarded $11.5 million to BioCrossroads since 2003 to advance the economic vitality of Indianapolis. 

Additional Posts

Is it better to allocate state resources to Pre-K, K-12 or both?

Alex Cohen is the Director of Learning and Evaluation for the Richard M. Fairbanks Foundation. Early childhood investments like state-funded Pre-K targeting low-income students have received a lot of attention in Indiana lately. At the same time, state and local leaders continue to grapple with how to improve test scores and graduation rates in K-12 […]

Needle Exchange: An Important Tool for Addressing the Opioid Epidemic

Alex Cohen is the Director of Learning and Evaluation for the Richard M. Fairbanks Foundation. The toll of the opioid epidemic is often measured in lives lost due to overdose—and for good reason. It’s estimated that, across the United States, 115 people die of opioid overdose every day. But the impact of opioids can also […]